Skip to content
10-Q

Quarterly Report

Impact BioMedical, INC. IBO

0001493152-24-031635

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 1, 2024 10M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $2K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $1K
Stockholders Equity Q2 2024 · Jun 30, 2024 $23.37M
Stockholders Equity Q2 2024 · Dec 31, 2023 $25.22M
Current Liabilities Q2 2024 · Jun 30, 2024 $14.5M
Current Liabilities Q2 2024 · Dec 31, 2023 $13.14M
Current Assets Q2 2024 · Jun 30, 2024 $307K
Current Assets Q2 2024 · Dec 31, 2023 $332K
Total Assets Q2 2024 · Jun 30, 2024 $44.12M
Total Assets Q2 2024 · Dec 31, 2023 $44.63M
Short Term Debt Q2 2024 · Sep 30, 2023 $11.9M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$1.75M
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.02
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.03
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.02
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.03
Sga Expense Q2 2024 · Jun 30, 2023 $41K
Sga Expense Q2 2024 · Jun 30, 2023 $81K
Rd Expense Q2 2024 · Jun 30, 2023 $266K
Rd Expense Q2 2024 · Jun 30, 2023 $445K
Net Income Q2 2024 · Jun 30, 2023 −$1.97M
Operating Income Q2 2024 · Jun 30, 2023 −$1.01M
Operating Income Q2 2024 · Jun 30, 2023 −$1.81M